Vimta Labs Limited (NSE:VIMTALABS)

Market Cap	20.17B -11.8%
Revenue (ttm)	4.07B +17.9%
Net Income	775.12M +16.1%
EPS	17.20 +16.2%
Shares Out	n/a
PE Ratio	26.02
Forward PE	n/a
Dividend	2.00 (0.44%)
Ex-Dividend Date	Jun 18, 2026

Volume	78,465
Average Volume	370,894
Open	453.50
Previous Close	450.30
Day's Range	447.55 - 456.25
52-Week Range	376.05 - 902.65
Beta	-0.18
RSI	45.20
Earnings Date	May 6, 2026

About Vimta Labs

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufactu...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 1,315
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VIMTALABS

Financial Performance

In fiscal year 2026, Vimta Labs's revenue was 4.07 billion, an increase of 17.93% compared to the previous year's 3.45 billion. Earnings were 775.12 million, an increase of 16.11%.